Jonathan Parker

  • Partner
  • Ejonathan.parker@lw.com
  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
  • T +44.20.7710.4513
  •  
 

Profile

Jonathan Parker is a partner in the Antitrust & Competition Practice in Latham & Watkins’ London office focusing on European and UK competition law.

Mr. Parker advises clients on a wide range of EU and UK competition issues, including mergers and acquisitions, market studies, cartels/restrictive agreements, and abuse of dominance cases.

Prior to joining Latham, Mr. Parker worked as a Legal Director and Director of Mergers at the UK Competition and Markets Authority (CMA). He is renowned in the market for deploying his considerable experience and institutionalized thinking on UK merger control matters.

Mr. Parker is a member of the Competition Law Committee of the City of London Law Society.

Experience

Mr. Parker's experience includes advising:

  • Facebook regarding the CMA's investigation into its acquisition of Giphy
  • Advanced Micro Devices (AMD) in its acquisition of Xilinx
  • KKR regarding the CMA’s investigation into its acquisition of OverDrive
  • iZettle in relation to the CMA’s Phase 2 investigation into its acquisition by PayPal
  • Rowan Companies in relation to the CMA’s investigation into its merger with Ensco
  • Electro Rent Corporation in relation to the CMA’s Phase 2 investigation of its acquisition of Microlease Inc and the subsequent CAT appeal
  • Integra LifeSciences of the CMA’s investigation into its acquisition of Codman’s Neurosurgery business
  • Survitec Group in relation to the CMA’s investigation into its acquisition of the marine safety business of Wilhelmsen Maritime Services AS
  • Hytera Communications in relation to the Secretary of State’s public interest intervention regarding its acquisition of Sepura
  • ACCO in relation to the CMA’s investigation into its acquisition of Esselte
  • Bain Capital in relation to the CMA’s investigation into its acquisition of Gruppo Cordenons
  • GTCR in relation to the UK merger filing for its acquisition of PR Newswire
  • A global pharmaceutical company in relation to the CMA’s Competition Act investigation into alleged excessive pricing of hydrocortisone tablets
  • A party in relation to the CMA’s civil and criminal investigation into suspect cartel arrangements in the supply of products to the construction industry

Thought Leadership

  • Impact of COVID-19 on Global Merger Control Reviews -  May 12, 2021
  • PE Views: Insights on the World of Private Equity -  December 16, 2020
  • UK Government Publishes Draft Legislation for a New Foreign Direct Investment Regime -  November 11, 2020
  • Foreign Investment Controls — Are We Seeing a More Nuanced Approach to Private Equity? -  June 15, 2020
  • Merger Control in Europe Following COVID-19 -  March 24, 2020
  • Deal Planning After Brexit — Merger Control Aspects -  January 29, 2020
  • Antitrust Clearance: Keeping Your Deal on Track -  June 24, 2019
  • Key Industry Lessons From the FCA's First Competition Law Case -  May 24, 2019
  • New National Security Threat to UK Private Equity Deals  -  November 06, 2018
  • Brexit and Global Antitrust Reviews: Practical Issues and Guidance  -  September 18, 2018
  • Private Equity Firms Must Evaluate Competition Strategy Ahead of Brexit  -  September 11, 2018
  • UK Adopts New Powers To Investigate Smaller Transactions Raising National Security Concerns -  June 11, 2018
  • New UK Government Powers Over Smaller Transactions Raising National Security Concerns -  June 06, 2018
  • CJEU Offers Improved Protection for Luxury Goods in Coty Ruling  -  December 13, 2017
  • CMA Imposes Fixed Penalty on Hungryhouse for Failure to Comply With Information Request -  December 07, 2017
  • CAT Upholds Fine for Unlawful Information Exchange at Single Meeting -  October 19, 2017
  • CMA Updates its Penalties Guidance for UK and EU Competition Law Infringements -  August 18, 2017
  • UK Competition and Markets Authority Increases Thresholds in Updated “De Minimis” Guidance -  June 16, 2017
  • Competition Appeal Tribunal Refuses Interim Relief in Pharma Pricing Case  -  February 01, 2017
  • UK Government Expected to Adopt a More Interventionist Approach to Takeovers and Critical Infrastructure Projects  -  September 29, 2016
  • New Foreign Investment Control of UK Critical Infrastructure Projects -  September 16, 2016
  • CMA Taking Increasingly Intrusive Approach To Monitoring UK Deals -  July 21, 2016

“Exceptionally good with clients and a really good technician”

"Standout merger control practitioner"

Chambers 2019-2021
Bar Qualification
  • England and Wales (Solicitor)
Education
  • Legal Practice Course, Oxford Institute of Legal Practice, 1999
  • Bachelor Degree in Law, University of Oxford, 1998
Practices
  • Antitrust & Competition
  • Litigation & Trial Practice